Tallenna
Drugs for HER-2-positive Breast Cancer
Growth factor receptors have long been known to drive malignant transformation and cancer progression. The epidermal growth factor receptor (EGFR, ErbB, HER) system is likely the best described membrane receptor tyrosine kinase family in malignant tumors.
- Toimittaja
- Maria Sibilia, Christoph C. Zielinski, Rupert Bartsch, Thomas W. Grunt
- ISBN
- 9783034600934
- Kieli
- englanti
- Paino
- 446 grammaa
- Julkaisupäivä
- 7.1.2011
- Kustantaja
- Birkhauser Verlag AG
- Sivumäärä
- 110
